Chen CJ, Shively JE. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association. with Src homology protein-1 and down-regulates IL-2 receptor. Journal of Immunology; 2004, 172(6): 3544-3552.
Cooper LJ, Al KZ, DiGiusto D, DiGiusto D, Kalos M, Colcher D, Raubitschek A, Forman SJ, Jensen MC. Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies. Blood Cells Molecules and Diseases; 2004, 33(1): 83-89.
Cooper LJ, Topp MS, Pinzon C, Plavec I, Jensen MC, Riddell SR, Greenberg PD. Enhanced transgene expression in quiescent and activated human CD8(+) T cells. Human Gene Therapy; 2004, 15(7): 648-658.
Cullinane CA, Ellenhorn JD, Weitzel JN. Microsatellite instability is a rare finding in tumors of patients with both primary renal and rectal neoplasms. Cancer Genetics and Cytogenetics; 2004, 148(2): 163-165.
Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors. Cancer Research; 2004, 64(15): 5407-5414.
Friedman RS, Bangur CS, Zasloff EJ, Fan LQ, Wang TT, Watanabe Y, Kalos M. Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. Journal of Immunology; 2004, 172(5): 3319-3327.
Friedman RS, Spies AG, Kalos M. Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate. European Journal of Immunology; 2004, 34(4): 1091-1101.
Gonzalez S, Naranjo A, Serrano LM, Chang WC, Wright CL, Jensen MC. Genetic engineering of cytotytic T lymphocytes for adoptive T-cell therapy of neuroblastoma. Journal of Gene Medicine; 2004, 6(6): 704-711.
Guo GZ, Wang TL, Gao Q, Tamae D, Wong P, Chen T, Chen WC, Shively JE, Wong JY, Li JJ. Expression of ErbB2 enhances radiation-induced NF-kappa B activation. Oncogene; 2004, 23(2): 535-545.
Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells. Cancer Research; 2004, 64(24): 9160-9166.
Kirshner J, Hardy J, Wilczynski S, Shively JE. Cell-cell adhesion molecule CEACAM1 is expressed in normal breast and milk and associates with beta 1 integrin in a 3D model of morphogenesis. Journal of Molecular Histology; 2004, 35(3): 287-299.
Olafsen T, Cheung CW, Yazaki PJ, Li L, Sundaresan G, Gambhir SS, Sherman MA, Williams LE, Shively JE, Raubitschek AA, Wul AM. Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications. Protein Engineering Design & Selection; 2004, 17(1): 21-27.
Olafsen T, Tan GJ, Cheung CW, Yazaki PJ, Park JM, Shively JE, Williams LE, Raubitschek AA, Press MF, Wu AM. Characterization of engineered anti-pI85(HER-2) (scFv-C(H)3)(2) antibody fragments (minibodies) for tumor targeting. Protein Engineering Design & Selection; 2004, 17(4): 315-323.
Qiu JZ, Liu R, Chapados BR, Sherman M, Tainer JA, Shen BH. Interaction interface of human flap endonuclease-1 with its DNA substrates. Journal of Biological Chemistry; 2004, 279(23): 24394-24402.
Reeve JR, Liddle RA, McVey DC, Vigna SR, Solomon TE, Keire DA, Rosenquist G, Shively JE, Lee TD, Chew P, Green GM, Coskun T. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties. American Journal of Physiology-Gastrointestinal and Liver Physiology; 2004, 287(2): G326-G333.
Schumann D, Jie HA, Clarke PE, Kirshner J, Tsai SW, Schumaker VN, Shively JE. Characterization of recombinant soluble carcinoembryonic antigen cell adhesion molecule 1. Biochemical and Biophysical Research Communications; 2004, 318(1): 227-233.
Shan L, Vincent J, Brunzelle JS, Dussault I, Lin M, Ianculescu I, Sherman MA, Forman BM, Fernandez EJ. Structure of the murine constitutive androstane receptor complexed to androstenol: A molecular basis for inverse agonism. Molecular Cell; 2004, 16(6): 907-917.
Wang JJ, Press OW, Lindgren CG, Greenberg P, Riddell S, Qian XJ, Laugen C, Raubitschek A, Forman SJ, Jensen MC. Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8(+) cytotoxic T lymphocytes. Molecular Therapy; 2004, 9(4): 577-586.
Wang ZD, La RC, Mekhoubad S, Lacey SF, Villacres MC, Markel S, Longmate J, Ellenhorn JD, Siliciano RF, Buck C, Britt WJ, Diamond DJ. Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood; 2004, 104(3): 847-856.
Wong JY, Chu DZ, Williams LE, Yamauchi DM, Ikle DN, Kwok CS, Liu A, Wilczynski S, Colcher D, Yazaki PJ, Shively JE, Wu AM, Raubitschek AA. Pilot trial evaluating an I-123-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer. Clinical Cancer Research; 2004, 10(15): 5014-5021.
Yazaki PJ, Sherman MA, Shively JE, Ikle D, Williams LE, Wong JY, Colcher D, Wu AM, Raubitschek AA. Humanization of the anti-CEA T84.66 antibody based on crystal structure data. Protein Engineering Design & Selection; 2004, 17(5): 481-489.
Kwok C, Williams L, Lopatin G, Wu A, Yazaki P, Shively J, Wong J, Raubitschek A. Prediction of pharmacokinetics of antibodies in human from mouse data. Cancer Biotherapy and Radiopharmaceuticals; 2004, 19(4): 536-537.
Williams L, Lopatin G, Frankel P, Kwok C, Wu A, Yazaki P, Yamauchi D, Shively J, Raubitschek A, Wong J. Using single kinetic parameters to distinguish cognate anti-CEA antibodies in the blood. Cancer Biotherapy and Radiopharmaceuticals; 2004, 19(4): 541-541.
Williams L, Kwok C, Wu A, Yazaki P, Shively J, Liu A, Raubitschek A, Wong J. Estimation of area under the curve (AUC), mean residence time (MRT) and associated errors for cognate monoclonal antibodies in the blood. Medical Physics; 2004, 31(6): 1756-1756.
Zhong LW, Wu CH, Lee WH, Liu CP. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways. Journal of Immunology; 2004, 172(3): 1472-1482.
